ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2023

Prevalence of Inflammatory Arthritis Conditions in the First Nations Population of Alberta

Cheryl Barnabe1, C. Allyson Jones2, Don Voaklander3, Deborah Marshall4, Christine Peschken5, Sasha Bernatsky6, John Esdaile7 and Brenda Hemmelgarn8, 1Division of Rheumatology, University of Calgary, Calgary, AB, Canada, 2Departments of Physical Therapy and School of Public Health, University of Alberta, Edmonton, AB, Canada, 3University of Alberta, Edmonton, AB, Canada, 4University of Calgary, Calgary, AB, Canada, 5Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 6Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 7Arthritis Research Centre of Canada, Richmond, BC, Canada, 8Division of Nephrology, University of Calgary, Calgary, AB, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: epidemiologic methods and rheumatoid arthritis (RA), Native Americans

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Public Health (ACR): Rheumatoid Arthritis Pathogenesis and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: Canada’s First Nations population reports higher rates of physician-diagnosed arthritis and rheumatism, and is known to have twice the rate of osteoarthritis. The prevalence of inflammatory arthritis conditions of Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA), Reactive Arthritis (ReA), and Crystal Arthritis has not been widely studied, although variations between FN populations based on tribal ancestry are hypothesized. The Alberta First Nations population is rich in diversity with numerous Tribal Nations represented, including Blackfoot, Chipewyan, Cree, Dene, Sarcee, Saulteaux and Sioux Nations.  Prevalence estimates from Alberta would therefore provide a good overall view of the arthritis landscape among First Nations populations in Canada. We report the prevalence of these inflammatory arthritis conditions in the population of Alberta, Canada, comparing rates in First Nations and non-First Nations.

Methods: Population-based healthcare administrative data (years 1993 to 2011), including physician billing claims and hospitalizations, was used to define cohorts of patients with RA, AS, Ps, ReA and crystal arthritis based on ICD-9-CA and ICD-10-CM codes (2 physician billing codes or 1 hospitalization). First Nations patients were identified based on premium payer status. Disease prevalence rates were calculated for fiscal year 2008/2009 as cases per 1000 persons, and the rate ratio calculated for First Nations relative to non-First Nations.

Results: RA, AS and ReA were estimated as being twice as frequent in the First Nations population (Table 1). In contrast, PsA was slightly less frequent in First Nations.  Crystal arthritis surpassed RA as the most frequent type of inflammatory arthritis in the non-First Nations population, with a rate ratio three times that of the First Nations cohort.

Table 1. Prevalence Rate of Inflammatory Arthritis Conditions in Alberta (per 1000 persons), and Rate Ratio for First Nations compared to non-First Nations

Condition

Prevalence Rate in First Nations

Prevalence Rate in non-First Nations

Rate Ratio (95%CI), p value

Rheumatoid Arthritis

19.00

10.51

1.81 (1.74-1.88), p<0.001

Psoriatic Arthritis

0.65

0.85

0.77 (0.62-0.94), p=0.0118

Ankylosing Spondylitis

3.58

2.08

1.72 (1.57-1.88), p<0.001

Reactive Arthritis

0.09

0.04

2.23 (1.23-4.02), p=0.0063

Crystal Arthritis

4.44

12.82

0.35 (0.32-0.37), p<0.001

Conclusion: Our estimates demonstrate that RA is the most frequent inflammatory arthritis in the First Nations population of Alberta, whereas crystal arthritis is the most frequent inflammatory arthritis diagnosis in non-First Nations. RA, AS and ReA prevalence estimates in First Nations are twice that of the non-First Nations population, whereas PsA and crystal arthritis are less frequent. These results further explain the higher self-reported rates of arthritis conditions in the First Nations population beyond degenerative arthritis conditions, and validate the need for enhanced inflammatory arthritis health services to address disease burden.


Disclosure:

C. Barnabe,
None;

C. A. Jones,
None;

D. Voaklander,
None;

D. Marshall,
None;

C. Peschken,
None;

S. Bernatsky,
None;

J. Esdaile,
None;

B. Hemmelgarn,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-inflammatory-arthritis-conditions-in-the-first-nations-population-of-alberta/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology